Literature DB >> 24392695

Sodium channels, inherited epilepsy, and antiepileptic drugs.

William A Catterall1.   

Abstract

Voltage-gated sodium channels initiate action potentials in brain neurons, mutations in sodium channels cause inherited forms of epilepsy, and sodium channel blockers-along with other classes of drugs-are used in therapy of epilepsy. A mammalian voltage-gated sodium channel is a complex containing a large, pore-forming α subunit and one or two smaller β subunits. Extensive structure-function studies have revealed many aspects of the molecular basis for sodium channel structure, and X-ray crystallography of ancestral bacterial sodium channels has given insight into their three-dimensional structure. Mutations in sodium channel α and β subunits are responsible for genetic epilepsy syndromes with a wide range of severity, including generalized epilepsy with febrile seizures plus (GEFS+), Dravet syndrome, and benign familial neonatal-infantile seizures. These seizure syndromes are treated with antiepileptic drugs that offer differing degrees of success. The recent advances in understanding of disease mechanisms and sodium channel structure promise to yield improved therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24392695     DOI: 10.1146/annurev-pharmtox-011112-140232

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  58 in total

Review 1.  Neurology--the next 10 years.

Authors:  Ralf Baron; Donna M Ferriero; Giovanni B Frisoni; Chetan Bettegowda; Ziya L Gokaslan; John A Kessler; Annamaria Vezzani; Stephen G Waxman; Sven Jarius; Brigitte Wildemann; Michael Weller
Journal:  Nat Rev Neurol       Date:  2015-10-27       Impact factor: 42.937

2.  Probing kinetic drug binding mechanism in voltage-gated sodium ion channel: open state versus inactive state blockers.

Authors:  Krishnendu Pal; Gautam Gangopadhyay
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

3.  Fenestrations control resting-state block of a voltage-gated sodium channel.

Authors:  Tamer M Gamal El-Din; Michael J Lenaeus; Ning Zheng; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-05       Impact factor: 11.205

4.  Disruption of Fgf13 causes synaptic excitatory-inhibitory imbalance and genetic epilepsy and febrile seizures plus.

Authors:  Ram S Puranam; Xiao Ping He; Lijun Yao; Tri Le; Wonjo Jang; Catherine W Rehder; Darrell V Lewis; James O McNamara
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

5.  Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.

Authors:  John Gilchrist; Stacey Dutton; Marcelo Diaz-Bustamante; Annie McPherson; Nicolas Olivares; Jeet Kalia; Andrew Escayg; Frank Bosmans
Journal:  ACS Chem Biol       Date:  2014-03-31       Impact factor: 5.100

Review 6.  [Update on the pharmacology and effects of local anesthetics].

Authors:  J Ahrens; A Leffler
Journal:  Anaesthesist       Date:  2014-05       Impact factor: 1.041

7.  Sodium channel subtypes are differentially localized to pre- and post-synaptic sites in rat hippocampus.

Authors:  Kenneth W Johnson; Karl F Herold; Teresa A Milner; Hugh C Hemmings; Jimcy Platholi
Journal:  J Comp Neurol       Date:  2017-08-11       Impact factor: 3.215

8.  Serotonergic agents act on 5-HT3 receptors in the brain to block seizure-induced respiratory arrest in the DBA/1 mouse model of SUDEP.

Authors:  Carl L Faingold; Marcus Randall; Chang Zeng; Shifang Peng; Xiaoyan Long; Hua-Jun Feng
Journal:  Epilepsy Behav       Date:  2016-10-12       Impact factor: 2.937

Review 9.  Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?

Authors:  Zhi-Mei Li; Li-Xia Chen; Hua Li
Journal:  Curr Med Sci       Date:  2019-12-16

Review 10.  Pharmacogenomics of cardiovascular complications in diabetes and obesity.

Authors:  Kalyan Chapalamadugu; Siva K Panguluri; Aimon Miranda; Kevin B Sneed; Srinivas M Tipparaju
Journal:  Recent Pat Biotechnol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.